Craneware the Edinburgh-based healthtech company which specialises in the US market has announced its audited results for the year ended 30 June 2018.
Total revenue has increased 16% to $67.1m, up from $57.8m in the previous year.
Adjusted EBITDA has increased 20% to $21.6m, up from $18.0m and profit before tax has increased 12% to $18.9m, up from $16.9m.
Highlights include a 100% increase in new sales in the year, including five significant contracts wins or contract extensions and a record sales pipeline for the current financial year.
Keith Neilson, CEO of Craneware plc commented, “While the past year has been outstanding in terms of financial results and operational progress, this is by no means the end of the journey and we are excited by the far greater opportunity that lies ahead. It is clear that the investments we have made into the organisation’s design, people and products are delivering excellent results, and we will continue to invest in our people and business to ensure we have the capabilities to succeed. We believe that the breadth of our customer base and the quantity of data within our solutions means we have the opportunity to sit at the heart of the move to value-based economics; collating and analysing the information that will support hospital-wide decision making and ultimately have a positive impact on the quality of healthcare.
“With an ongoing, growing market opportunity, a record sales pipeline and increasing long-term revenue visibility, we enter the new financial year with great confidence for the future and the ongoing success of the business.”